Showing results (151-160 of 253) with videos related to
Sort By:
Pageof 26
Gastroenterologie Clinique Et Biologique|September 14, 2010
A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacksA Baudet, J-F Colombel, A Cortot, et al.Gut|May 3, 2005
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel diseaseJ Halfvarson, A Standaert-Vitse, G Järnerot, et al.Journal of Crohn'S & Colitis|July 13, 2013
Serum calprotectin as a biomarker for Crohn's diseaseM-A Meuwis, G Vernier-Massouille, J C Grimaud, et al.Gastroenterology|July 1, 1988
Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultrastructural investigationsC Degott, B Messing, D Moreau, et al.Alimentary Pharmacology & Therapeutics|May 26, 2010
Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's diseaseP Zerbib, D Koriche, S Truant, et al.European Journal of Gastroenterology & Hepatology|November 24, 1999
Alpha1-antitrypsin phenotypes and anti-neutrophil cytoplasmic auto-antibodies in inflammatory bowel diseaseC Taddei, M A Audrain, D Reumaux, et al.Gut|January 13, 2001
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's diseaseA Cortot, J F Colombel, P Rutgeerts, et al.Neurogastroenterology and Motility|May 23, 2009
Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case-control studyS Hervé, L Beaugerie, Y Bouhnik, et al.Alimentary Pharmacology & Therapeutics|June 8, 2011
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's diseaseM A Kamm, S B Hanauer, R Panaccione, et al.Digestive Diseases and Sciences|December 1, 1996
Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responsesF Carbonnel, A Boruchowicz, B Duclos, et al.Pageof 26